News

28 September 2022

Dexa Group is Committed to Improving Health Services through Renovation Assistance for Inpatient Rooms at TNI AD Hospital, dr. AK Gani Palembang

Following the 53rd anniversary, Dexa Group and the Indonesian Army Health Center officially opened the renovated inpatient room at the Tk II Hospital, dr. AK Gani, Palembang. Dexa Group's devotion to providing public health services and support for the National Health Insurance (JKN) program can be seen in the refurbishment…
12 September 2022

Synergy of Dexa Group, National Population, and Family Planning Agency, and Indonesian Midwives Association to Pursue a 14% Reduction of Stunting in 2024

According to the Indonesian Toddler Nutrition Status Survey (SSGBI), the incidence of stunting in Indonesia remains at 24.4%, much behind the 14% objective set by the 2020-2024 National Medium-Term Development Plan (RPJMN). For that purpose, Dexa Group cooperated with the National Population and Family Planning Agency (BKKBN) to host a…
1 September 2022

More Than 17 Years Trusted by Indonesian Families, STIMUNO Wins Indonesian Mom's Favorite Brand Choice Awards 2022

For more than 17 years, STIMUNO, the first phytopharmaca immunomodulator in Indonesia, had been relied on by the Indonesian Family to support the health of their immune systems. For this accomplishment, STIMUNO earned the Top 5 Indonesian Mom's Favorite Brands for Multivitamin Category in the Household & Personal Care (non-food)…
28 January 2022

STIMUNO Kids Wins Indonesia Mom's Favorite Kids Brand Awards 2022

STIMUNO Kids won the Indonesia Mom's Favorite Kids Brand Awards 2022 for its performance in becoming one of the favorite vitamin products in 2021. This prize was granted by HerStory, a WartaEkonomi.co.id company that focuses on women's concerns ranging from health to life. With the theme "The Power Of Mother's…
28 January 2022

Dexa Group Wins the Indonesia Corporate Public Relations Award for the 4th time

Dexa Group was awarded The Best Indonesia Public Relations Award in the Pharmaceutical Category by the Indonesia Corporate Public Relations Award (IPRA) 2022 for its performance in Corporate Public Relations. Dexa Group has won the IPRA Award for the fourth time since 2018. With the theme "Creating Impact for a…
26 January 2022

Dexa Group Molecular Pharmacologist Dr. Raymond Tjandrawinata Ranked 1st in the World Scientific Ranking Index

Dr. Raymond Tjandrawinata, a Molecular Pharmacologist who is a researcher of various types of drugs ranging from chemical to biologic, and the founder of Indonesian Original Modern Medicine (OMAI), took first place in the ranks of 100 world scientists in the field of medicine and health for the territory of…
25 December 2021

Dexa Group Wins Top CSR Program Award 2021 from West Java Provincial Government

Dexa Group through Dharma Dexa has been awarded Corporate Social Responsibility by the West Java Provincial Government in recognition of their contributions to the implementation of social and environmental responsibility programs in the West Java Area. The virtual ceremony was held by Regional Development Planning Agency/Bappeda of West Java Province…
17 December 2021

CEO Dexa Group Achieved Most Acclaimed CEO Award 2021

For the ability to adapt and continue to innovate to maintain the continuity of the company's business activities, CEO Dexa Group Mr. Ferry Soetikno received the "Indonesia Most Acclaimed CEO Award 2021" with Outstanding Leadership in Expanding Corporate Business Segmentation in the pharmaceutical category from WartaEkonomi.co.id. The Most Acclaimed CEO…
15 December 2021

Dexa Group Donates Medicines through BNPB for Semeru Eruption Victims

The national pharmaceutical company Dexa Group participated in donating a number of medicines through the National Disaster Management Agency (BNPB) to treat the health of residents affected by the eruption of Mount Semeru in Lumajang, East Java. According to BPNP data on December 6, 2021, residents affected by the eruption…
8 December 2021

Dexa Group Appreciated by Government for Contribution to Improving National Industry Competitiveness through OMAI Research and Innovation

Taking an active role in increasing the competitiveness of the national industry through research and sustainable technological innovation in the pharmaceutical sector, Dexa Laboratories of Biomolecular Sciences (DLBS) received the Rintisan Teknologi Industri 2021 award from the Ministry of Industry of the Republic of Indonesia. The award was handed over…